ask="27.4600"
ask_size="5000"
average_daily_volume="15290"
bid="N/A"
bid_size="N/A"
book_value="0.0000"
change="-0.2701"
change_from_200_day_moving_average="1.1743"
change_from_50_day_moving_average="1.3978"
change_from_52_week_high="-2.0001"
change_From_52_week_low="4.9099"
change_in_percent="-1.0918%"
close="24.4699"
dividend_pay_date="1/4/2016"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="N/A"
ebitda="0.00"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="N/A"
ex_dividend_date="12/29/2015"
float_shares="N/A"
high="24.8600"
high_52_weeks="26.4700"
last_trade_date="3/16/2017"
last_trade_price="24.4699"
last_trade_size="200"
last_trade_time="3:46pm"
low="24.3400"
low_52_weeks="19.5600"
market_capitalization="24.47B"
moving_average_200_day="23.2956"
moving_average_50_day="23.0721"
name="Loncar Cancer Immunotherapy ETF"
notes="N/A"
one_year_target_price="N/A"
open="24.8600"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+5.0409%"
percent_change_from_50_day_moving_average="+6.0584%"
percent_change_from_52_week_high="-7.5561%"
percent_change_from_52_week_low="+25.1017%"
previous_close="24.7400"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="1000000000"
short_ratio="0.0000"
stock_exchange="NGM"
symbol="CNCR"
volume="6158"
weeks_range_52="19.5600 - 26.4700"
